Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over study.
Masquelier B, Descamps D, Carrière I, Ferchal F, Collin G, Denayrolles M, Ruffault A, Chanzy B, Izopet J, Buffet-Janvresse C, Schmitt MP, Race E, Fleury HJ, Aboulker JP, Yeni P, Brun-Vézinet F.
Masquelier B, et al. Among authors: izopet j.
Antivir Ther. 1999;4(2):69-77.
Antivir Ther. 1999.
PMID: 10682151
Clinical Trial.